Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
about
Statins and fibrates for preventing melanomaStatin adverse effects : a review of the literature and evidence for a mitochondrial mechanismThe effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]Cholesterol lowering and mortality: the importance of considering initial level of riskCholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trialsLipid-lowering update 2001. Aggressive new goalsStatins for primary prevention: at what coronary risk is safety assured?Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.Influences of age, sex, and LDL-C change on cardiovascular risk reduction with pravastatin treatment in elderly Japanese patients: A post hoc analysis of data from the Pravastatin Anti-atherosclerosis Trial in the Elderly (PATE)The neuropsychopharmacology of criminality and aggression.Epidemiological link between low cholesterol and suicidality: a puzzle never finished.Is low total cholesterol levels associated with suicide attempt in depressive patients?The fact and fiction of lowering cholesterol concentrations in the primary prevention of coronary heart disease.Cholesterol and affective morbidityA controlled study of serum lipid profiles in Indian patients with depressive episode.Randomised controlled trial in northern England of the effect of a person knowing their own serum cholesterol concentration.Serum lipids and mood in working men and women in SwedenCost effectiveness and equity of a community based cardiovascular disease prevention programme in Norsjö, Sweden.Can we use biomarkers in combination with self-reports to strengthen the analysis of nutritional epidemiologic studies?Depression as a risk factor for ischaemic heart disease in men: population based case-control study.Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke.Cholesterol, heart disease and the brain: an opportunity in research and a disaster in public health education?Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors.Lipid-lowering medication use and aggression scores in women: a report from the NHLBI-sponsored WISE study.Screening in the elderly: principles and practice.Is hypercholesterolemia a risk factor and should it be treated in the elderly?Suicidal behavior in schizophrenia may be related to low lipid levels.The association of low serum cholesterol with depression and suicidal behaviours: new hypotheses for the missing link.The mood cycle hypothesis: possible involvement of steroid hormones in mood regulation by means of Na+, K+-ATPase inhibition.Serum lipid profile in suicide attempters.Lessons for atherosclerosis research from tuberculosis and peptic ulcer.Stress responses after treatment of hypercholesterolaemia with simvastatin.Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers.Lipid correlates of attentional impulsivity in first episode mania: results from an Indian populationUse of fibrates and cancer risk: a systematic review and meta-analysis of 17 long-term randomized placebo-controlled trialsCholesterol, mood, and vascular health: Untangling the relationship: Does low cholesterol predispose to depression and suicide, or vice versa?Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts.Understanding the neurobiology of suicidal behavior.Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits.Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm
P2860
Q24245521-12AA05CB-A41F-469C-B883-345648DE99F4Q24603957-7C4952A2-5D44-4CF3-A06F-7B0F30647918Q24793837-497E2F00-4107-4BC5-B84E-AECEC6E2232DQ28270339-7BE7E399-684E-4967-B8D3-B807C983BFB9Q28345598-AD5FE0D6-A5FE-412B-8B5B-3B569CFED70AQ28354365-03A738B3-AF70-433D-9412-FECAFC535374Q28362569-FD2D30D1-2CC6-408B-8568-67C45F4B0C9BQ29029379-2D59105C-3DB3-4CDD-95BB-222800A3ABEDQ30787990-ECCACDE3-A4C1-4B92-8455-E76A404576B8Q32061351-A2020FE5-AB4B-4912-9FD6-17B912A18A04Q33352441-24741C8D-125B-49C9-A57C-67ADA367CE18Q33568573-C0A82AFB-402E-4EA7-806B-9E0863165DE2Q33613238-EE600CCB-BF8E-49D3-BFBA-45F8CFB244E1Q33624225-66A937D7-F55F-4831-9C89-5374DD627424Q33652324-F38DCC27-7739-4F01-AD75-A274C8FEF5E9Q33702194-2336048F-E254-452A-9B83-52BFF5ECB89EQ33702532-A60DD23F-48AC-4C36-901F-7B278459F760Q33703502-17D8FC57-AD49-4DAD-8DCC-12291E321EC6Q33738935-A59C6DE3-0E9C-415A-9E3C-6A3F7E1A31BBQ33800924-57FC5C4B-DA19-422D-AFB5-88BD9150F661Q33815841-40736B82-CA68-449F-B0E0-87D1CFD17439Q33921149-1DFF07C9-90C8-4708-A108-A3845E63A26DQ33942127-BE524AA1-DD3A-45B0-B13D-20610CDBA536Q33958299-C8215A37-3660-4241-A24F-877807D1C6A9Q34072081-9950CC92-5119-401E-B4ED-3B6FE9641DD1Q34077942-CFDBDC16-F537-44AD-8C70-3A8A030EE182Q34105157-8347E02E-6302-4AF3-940C-8CEC6F2D8CFDQ34146972-6470EA67-C060-4C50-97F4-E85442FA1F0FQ34181229-C96F83EB-52C6-4E3B-9A2E-3F1E53A245E3Q34239262-14AFE452-33C1-4169-A5F4-CB0C41D74AEFQ34278447-65AE25C6-8A71-4F23-BFDD-13927B278054Q34345675-55DEB5DD-6CF2-4D6C-B6FF-E05F390FC2C3Q34346101-1AC9F491-18D3-41EF-8877-A7E13C0AB728Q34363711-07B751C8-8718-41FA-8625-4FAD29D7345AQ34428524-AB11F00C-3800-4669-B233-3BD42D068777Q34432313-E90E9CD8-F829-4AE3-8A8B-A5140105E7A5Q34464265-4F6464C3-FB1C-42E6-B32E-FB2C3A880645Q34465051-6B37E864-4F31-4EA7-A69F-935A25B4AFB2Q34712222-4A54B4E6-AD58-40EA-BB3E-AA6B07821F6BQ34712649-E3046990-E12A-4BEB-B679-283030AF480C
P2860
Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.
description
1990 nî lūn-bûn
@nan
1990 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Lowering cholesterol concentra ...... of primary prevention trials.
@ast
Lowering cholesterol concentra ...... of primary prevention trials.
@en
type
label
Lowering cholesterol concentra ...... of primary prevention trials.
@ast
Lowering cholesterol concentra ...... of primary prevention trials.
@en
prefLabel
Lowering cholesterol concentra ...... of primary prevention trials.
@ast
Lowering cholesterol concentra ...... of primary prevention trials.
@en
P2093
P2860
P356
P1433
P1476
Lowering cholesterol concentra ...... of primary prevention trials.
@en
P2093
K A Matthews
M F Muldoon
S B Manuck
P2860
P304
P356
10.1136/BMJ.301.6747.309
P407
P577
1990-08-01T00:00:00Z